Portfolio company
Leucadia Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an implantable medical device to restore cerebrospinal fluid flow for patients with Alzheimer's disease and mild cognitive impairment.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
LEUCADIA
This company develops medical devices and diagnostic tools designed to restore cerebrospinal fluid flow for patients at risk of or suffering from Alzheimer's disease.
Cogniguard
This company develops non-invasive vagus nerve stimulation medical devices to treat patients with Alzheimer's disease and mild cognitive impairment.
Sinaptica Therapeutics
The company develops non-invasive neuromodulation systems for Alzheimer's patients to slow cognitive decline using personalized brain stimulation technology.
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
Applied Cognition
The company develops non-invasive glymphatic system monitoring platforms and drug therapies for patients with neurological disorders like Alzheimer's and Parkinson's.
Aliada Therapeutics
This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.
